RUBCNL

RUBCNL (Pacer/C13ORF18) is an autophagy enhancer that promotes the maturation of autophagosomes into autolysosomes by engaging both the class III phosphatidylinositol 3-kinase (PtdIns3K) complex and the HOPS complex, with hepatocyte-specific loss in mice causing impaired autophagy flux, glycogen and lipid accumulation, and liver fibrosis (PMID:30894088). It executes this function through direct interaction with BECN1, mediating recruitment and activity of the class III PtdIns3K complex (PMID:37615625). RUBCNL activity is gated by a nutrient-sensitive modification switch: MTORC1-mediated phosphorylation inactivates it under nutrient-rich conditions, while starvation triggers dephosphorylation and GSK3-KAT5/TIP60-mediated acetylation that enhances HOPS recruitment and accelerates maturation (PMID:30894088). Beyond autophagy, RUBCNL forms a complex with RIPK1 that disassembles upon TNF stimulation, and through this interaction it limits assembly of the RIPK1-TNFR1 complex I and suppresses RIPK1 kinase-dependent apoptosis and necroptosis; mutants lacking autophagy-regulatory function retain this cell-death-suppressive activity, establishing the two roles as separable (PMID:38873940). RUBCNL expression is epigenetically controlled, being transcriptionally driven by histone H3K18 lactylation in hypoxic tumor cells (PMID:37615625) and silenced by promoter hypermethylation in cervical cancer, where its re-expression inhibits growth and induces apoptosis (PMID:23522960).

1. 2013 Medium

   Before its autophagy role was known, RUBCNL (then C13ORF18) was characterized as an epigenetically silenced gene whose re-expression has tumor-suppressive consequences, establishing the first functional link to cell growth control.

   Evidence Artificial transcription factor-mediated re-expression in hypermethylated cervical cancer lines with proliferation and apoptosis assays and methylation analysis

   PMID:23522960

   Open questions at the time

   • molecular mechanism downstream of re-expression not characterized
   • no connection drawn to autophagy at this stage
   • tumor-suppressor role tested only in cervical cancer cell lines
2. 2019 High

   Established RUBCNL/Pacer as an autophagy maturation factor by showing it engages both the class III PtdIns3K and HOPS complexes to drive autolysosome formation, with in vivo loss causing metabolic and fibrotic liver pathology.

   Evidence Hepatocyte-specific knockout mice plus in vitro/in vivo autophagy flux assays

   PMID:30894088

   Open questions at the time

   • structural basis of dual PtdIns3K/HOPS engagement not resolved
   • interaction interfaces not mapped
3. 2019 High

   Defined how RUBCNL activity is tied to nutrient status, identifying an inactivating MTORC1 phosphorylation and a starvation-induced GSK3-KAT5/TIP60 acetylation that boosts HOPS recruitment.

   Evidence Phospho/acetylation biochemistry with kinase-pathway manipulation and functional autophagy readouts

   PMID:30894088

   Open questions at the time

   • specific modified residues and their stoichiometry under physiological conditions not fully detailed
   • phosphatase mediating dephosphorylation not identified
4. 2023 High

   Connected RUBCNL to disease-relevant transcriptional control by showing tumor lactate-driven H3K18 lactylation upregulates RUBCNL, which then promotes BECN1-dependent autophagosome maturation to support hypoxic tumor survival and drug resistance.

   Evidence Histone lactylation/chromatin assays, reciprocal Co-IP for RUBCNL-BECN1, patient-derived organoid and xenograft models, loss-of-function

   PMID:37615625

   Open questions at the time

   • whether lactylation regulates RUBCNL in non-tumor settings unknown
   • direct binding interface with BECN1 not mapped
5. 2024 High

   Revealed an autophagy-independent function: RUBCNL complexes with RIPK1 to restrain TNF-induced apoptosis and necroptosis, with domain-separation mutants proving the cell-death and autophagy roles are genetically separable.

   Evidence Co-IP, proximity ligation assay, siRNA loss-of-function and gain-of-function, domain-separation mutants, TNF-induced death assays in mesenchymal stem cells

   PMID:38873940

   Open questions at the time

   • structural basis for RIPK1 complex assembly/disassembly not defined
   • whether this role generalizes beyond mesenchymal stem cells untested
6. 2024 Medium

   Tested the assumption that more RUBCNL means more autophagy and found the opposite in neurons, where overexpression worsened ALS pathology and SOD1 aggregation, indicating proteostasis requires balanced RUBCNL levels.

   Evidence Neuron-specific PACER overexpression crossed with SOD1G93A mice, in vitro neuronal overexpression, aggregate quantification, disease-course monitoring

   PMID:39551782

   Open questions at the time

   • mechanism by which excess RUBCNL impairs autophagy unresolved
   • unexpected gain-of-function result not independently confirmed
   • relevance to non-SOD1 neurodegeneration unknown
7. 2023 Low

   Placed RUBCNL downstream of Syk/mTOR signaling in regulating inflammatory neutrophil autophagy in colitis, extending its pathway context to immune regulation.

   Evidence RNA-seq, Syk pharmacological inhibition, qRT-PCR/Western blot, DSS-induced murine colitis model

   PMID:37941642

   Open questions at the time

   • pathway placement inferred from pharmacology and expression without direct mechanistic dissection of RUBCNL's role
   • no demonstration that RUBCNL itself is the effector of Syk inhibition

• How the dual PtdIns3K/HOPS engagement, the nutrient-sensitive modification switch, and the RIPK1-binding cell-death function are structurally organized within RUBCNL, and how RUBCNL dosage produces opposing autophagy outcomes, remain unresolved.
• no structural model of RUBCNL or its complexes
• no resolution of how excess protein impairs rather than enhances autophagy
• binding interfaces with BECN1, HOPS, and RIPK1 not mapped